Your browser is no longer supported. Please, upgrade your browser.
Settings
OPK OPKO Health, Inc. daily Stock Chart
OPK [NASD]
OPKO Health, Inc.
Index- P/E- EPS (ttm)-0.43 Insider Own1.60% Shs Outstand573.79M Perf Week8.64%
Market Cap3.61B Forward P/E- EPS next Y-0.19 Insider Trans68.13% Shs Float326.48M Perf Month42.95%
Income-238.60M PEG- EPS next Q-0.07 Inst Own25.10% Short Float22.42% Perf Quarter102.25%
Sales1.03B P/S3.52 EPS this Y-789.40% Inst Trans-0.15% Short Ratio12.16 Perf Half Y36.74%
Book/sh3.26 P/B1.93 EPS next Y32.10% ROA-12.00% Target Price11.90 Perf Year3.97%
Cash/sh- P/C- EPS next 5Y52.05% ROE-16.30% 52W Range2.66 - 7.24 Perf YTD28.37%
Dividend- P/FCF- EPS past 5Y-30.80% ROI-10.80% 52W High-15.47% Beta1.85
Dividend %- Quick Ratio0.90 Sales past 5Y86.70% Gross Margin39.60% 52W Low130.08% ATR0.33
Employees6030 Current Ratio1.10 Sales Q/Q-4.30% Oper. Margin-27.40% RSI (14)70.69 Volatility7.66% 6.63%
OptionableYes Debt/Eq0.11 EPS Q/Q-24.70% Profit Margin-31.30% Rel Volume1.41 Prev Close6.29
ShortableYes LT Debt/Eq0.09 EarningsAug 07 AMC Payout- Avg Volume6.02M Price6.12
Recom2.20 SMA2018.72% SMA5034.88% SMA20032.76% Volume8,356,521 Change-2.70%
Mar-02-18Downgrade JP Morgan Neutral → Underweight
Sep-14-17Downgrade JP Morgan Overweight → Neutral
Jun-21-16Reiterated Standpoint Research Buy $16 → $18
Jun-03-16Initiated Standpoint Research Buy $16
Mar-31-16Reiterated Barrington Research Outperform $17 → $16
Oct-16-15Initiated JP Morgan Overweight $14
Sep-11-15Downgrade Jefferies Buy → Hold
Mar-03-15Downgrade Oppenheimer Outperform → Perform
May-12-14Reiterated Oppenheimer Outperform $13 → $12
Mar-14-14Initiated Oppenheimer Outperform $13
Nov-13-13Reiterated Ladenburg Thalmann Buy $10 → $14.50
May-30-13Reiterated Ladenburg Thalmann Buy $8.50 → $10
Oct-22-12Initiated Barrington Research Outperform $6
Dec-01-11Reiterated Ladenburg Thalmann Buy $6 → $8.50
Jul-14-11Initiated Ladenburg Thalmann Buy $6
Jul-18-18 08:23AM  OPKO Health's RAYALDEE Gets Approval in Canada to Treat CKD Zacks
Jul-17-18 08:26AM  Here's Why You Should Hold Onto Opko Health (OPK) Stock Now Zacks
07:25AM  Free Technical Research on OPKO Health and Three More Biotech Equities ACCESSWIRE
Jul-16-18 11:57AM  OPKO Partner Vifor Fresenius Receives Marketing Approval for RAYALDEE in Canada GlobeNewswire
Jul-12-18 07:00PM  Why OPKO Health Jumped 21.1% in June Motley Fool
12:54PM  Harry Boxers four health-care stocks to watch MarketWatch
Jul-10-18 08:20AM  Today's Research Reports on Trending Tickers: OPKO Health and Depomed ACCESSWIRE
Jul-09-18 08:20AM  Today's Research Reports on Trending Tickers: OPKO Health and Endo International ACCESSWIRE +5.95%
Jul-06-18 09:02AM  Options Traders Expect Huge Moves in OPKO Health (OPK) Stock Zacks +7.87%
Jun-25-18 04:32PM  Opko Health (OPK) Rallies on Q1 Earnings and Revenue Beat Zacks
10:44AM  An Intrinsic Calculation For OPKO Health Inc (NASDAQ:OPK) Shows Its 34.41% Undervalued Simply Wall St.
Jun-12-18 08:00AM  GeneDx Announces Completion of 100,000 Exome Sequences GlobeNewswire
Jun-11-18 08:20AM  Today's Research Reports on Trending Tickers: Valeant Pharmaceuticals and OPKO Health ACCESSWIRE
08:00AM  OPKO Health Completes Enrollment in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes and Obesity GlobeNewswire
Jun-09-18 01:53PM  Why OPKO Health, Inc. Stock Rocketed Higher in May Motley Fool
Jun-05-18 06:13PM  Lifshitz & Miller LLP Announces Investigation of Cadus Corporation, CYS Investments, Inc., Gener8 Maritime, Inc. KLX Inc., OPKO Health, Inc., Recro Pharma, Inc., Vectren Corporation and Xcerra Corporation PR Newswire
May-31-18 08:35PM  Cramer's lightening round: I wouldn't be shocked if Sanof... CNBC Videos
May-23-18 07:10AM  Jim Cramer Shares His Thoughts On Altria, Corning And More Benzinga
May-22-18 02:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health, Inc. - OPK ACCESSWIRE
12:27PM  Under Armour, Valero, And 3 Other Stocks In Strong Directional Trends This Week Benzinga
07:00AM  Free Technical Insights on OPKO Health and Three Other Biotech Stocks ACCESSWIRE
May-21-18 01:39PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health, Inc. - OPK PR Newswire -6.77%
May-19-18 04:10PM  Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching Benzinga
May-18-18 04:31PM  Why Baidu, GameStop, and Opko Health Slumped Today Motley Fool -18.24%
02:34PM  Better Buy: Opko Health, Inc. (OPK) vs. Myriad Genetics (MYGN) Motley Fool
11:43AM  Here's Why OPKO Health Dropped as Much as 23% Today Motley Fool
09:12AM  OPKO Plans to Address Draft Local Coverage Determination Published by Novitas Solutions for 4Kscore Test GlobeNewswire
May-17-18 08:00AM  Today's Research Reports on Trending Tickers: OPKO Health and Ligand Pharmaceuticals ACCESSWIRE
May-16-18 07:45AM  Recent Analysis Shows H&R Block, Opko Health, Geron, Cardinal Health, Corning, and Intrexon Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire +5.72%
May-15-18 08:00AM  Today's Research Reports on Trending Tickers: OPKO Health and Halozyme Therapeutics ACCESSWIRE
May-12-18 07:17AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
May-11-18 01:46AM  Edited Transcript of OPK earnings conference call or presentation 8-May-18 8:30pm GMT Thomson Reuters StreetEvents
May-10-18 08:20AM  Todays Research Reports on Stocks to Watch: OPKO Health and Bellicum Pharmaceuticals ACCESSWIRE
07:40AM  Jim Cramer Advises His Viewers On Zendesk, Box And More Benzinga
May-09-18 07:03PM  Cramer's lightning round: The market's wrong on Constella... CNBC Videos +29.19%
11:53AM  Why Opko Health, Inc. Stock Is Soaring Today Motley Fool
08:30AM  Today's Research Reports on Trending Tickers: OPKO Health and Valeant Pharmaceuticals ACCESSWIRE
07:48AM  Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway Benzinga
05:07AM  OPKO Health: 1Q Earnings Snapshot Associated Press
May-08-18 04:05PM  OPKO Health Reports First Quarter 2018 Financial Results GlobeNewswire
May-06-18 06:19PM  The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More Benzinga
May-04-18 10:50AM  Insider Buying Report - (NASDAQ: OPK) Opko Health, Inc. ACCESSWIRE
May-02-18 10:00AM  OPKO Health to Announce First Quarter 2018 Financial Results on May 8, 2018 GlobeNewswire
May-01-18 08:55AM  OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories GlobeNewswire
Apr-27-18 04:30PM  OPKO Health to Remain on the Tel Aviv Stock Exchange GlobeNewswire
Apr-07-18 09:33AM  Is Opko Health, Inc. a Buy? Motley Fool
Mar-28-18 03:04PM  Ladenburg Thalmann launches behavioral finance program for advisors American City Business Journals
Mar-27-18 07:10AM  Wired News OPKO Health Announced Enrollment of First Patient in Phase-2b Trial of OPK88003 to Treat Type-2 Diabetes ACCESSWIRE
Mar-23-18 08:00AM  OPKO Health Enrolls First Patient in Phase 2b Study of OPK88003 to Treat Type 2 Diabetes GlobeNewswire
Mar-16-18 08:00AM  OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology GlobeNewswire +10.09%
Mar-12-18 09:10AM  Todays Research Reports on Trending Tickers: Intrexon and Opko Health ACCESSWIRE
09:00AM  Todays Research Reports on Trending Tickers: QEP Resources and Exxon Mobil ACCESSWIRE
Mar-08-18 08:50AM  Implied Volatility Surging for Opko Health (OPK) Stock Options Zacks
Mar-05-18 01:59PM  Here's Why Opko Health Inc. Fell in February Motley Fool +5.04%
08:51AM  Opko Health (OPK) in Focus: Stock Moves 6% Higher Zacks
08:11AM  OPKO Health (OPK) Q4 Earnings Decline Y/Y, Margins Down Zacks
Mar-02-18 10:15PM  Edited Transcript of OPK earnings conference call or presentation 1-Mar-18 9:30pm GMT Thomson Reuters StreetEvents +5.97%
03:05PM  Opko Health revenue, profits take a hit in Q4, shares fall 15% American City Business Journals
08:20AM  Todays Research Reports on Trending Tickers: Omeros and Opko Health ACCESSWIRE
08:19AM  Benzinga Pro's 7 Stocks To Watch Today Benzinga
Mar-01-18 06:48PM  OPKO Health reports 4Q loss Associated Press -6.19%
04:05PM  OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results GlobeNewswire
11:10AM  Opko Health Q4 Earnings Preview Benzinga
Feb-26-18 04:05PM  OPKO Health to Announce Fourth Quarter and Year End 2017 Financial Results on March 1, 2018 GlobeNewswire
Feb-25-18 05:01PM  Benzinga's Insider Buys Of The Week: Allergan, HCA, Opko And More Benzinga
Feb-01-18 07:45AM  New Research Coverage Highlights Washington Trust, National Research, Bassett Furniture Industries, Mondelez International, Opko Health, and Boeing Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Jan-30-18 07:31AM  Could Opko Health Inc. Be a Millionaire-Maker Stock? Motley Fool
Jan-27-18 04:29PM  Benzinga's Insider Buys Of The Week: BeiGene, Opko Health And More Benzinga
Jan-26-18 03:10PM  Opko Health announces resignation of diagnostic lab president American City Business Journals
08:00AM  OPKO Health Announces Leadership Changes at BioReference Laboratories GlobeNewswire
Jan-17-18 08:20AM  Todays Research Reports on Trending Tickers: AVEO Pharmaceuticals and Opko Health ACCESSWIRE
Jan-12-18 08:00AM  OPKOS GeneDx Announces Research Collaboration with Radboud University Medical Center GlobeNewswire
Dec-29-17 12:24PM  ETFs with exposure to OPKO Health, Inc. : December 29, 2017 Capital Cube
Dec-18-17 04:06PM  ETFs with exposure to OPKO Health, Inc. : December 18, 2017 Capital Cube
Dec-10-17 10:26AM  Why Opko Health Stock Stumbled in November Motley Fool
Dec-07-17 02:25PM  ETFs with exposure to OPKO Health, Inc. : December 7, 2017 Capital Cube
Dec-05-17 09:01AM  OPKO Health, Inc. :OPK-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017 Capital Cube
Nov-29-17 08:20AM  Todays Research Reports on Trending Tickers: BioLineRx Ltd. and Opko Health, Inc. ACCESSWIRE
Nov-27-17 11:02AM  OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy GlobeNewswire
08:15AM  Report: Developing Opportunities within PayPal, Exelixis, International Business Machines, Opko Health, Envision Healthcare, and Zynga Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-16-17 07:06PM  Cramer's lightning round: After Opko Health's quarter, it... CNBC Videos
06:50PM  Cramer's lightning round: After Opko Health's quarter, it's a 'neighborhood of pain' CNBC
Nov-15-17 09:31PM  Is Opko Health Inc. a Buy? Motley Fool
07:05AM  Xenetic Biosciences Reports 2017 Third Quarter Financial Results and Provides Corporate Update Business Wire
Nov-12-17 03:53AM  Edited Transcript of OPK earnings conference call or presentation 8-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-10-17 08:42AM  OPKO Health (OPK) Posts Wider-Than-Estimated Loss in Q3 Zacks
08:00AM  Todays Research Reports on Trending Tickers: Opko Health and Omeros Corporation ACCESSWIRE
Nov-09-17 08:55AM  Opko Health Investors Got Spooked Today, But Analyst Louise Chen Bets on Long-Term Sales Potential SmarterAnalyst -16.05%
02:02AM  OPKO Health, Inc. is trading above its 50 day moving average : OPK-US : November 9, 2017 Capital Cube
Nov-08-17 04:30PM  Opko Health Inc. (OPK) Announces 3Q:17 Financial Results; Shares Tumble SmarterAnalyst
04:05PM  OPKO Health Reports 2017 Third Quarter Highlights and Financial Results GlobeNewswire
Nov-07-17 08:00AM  OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform GlobeNewswire
Nov-03-17 01:05PM  OPKO Health, Inc. Value Analysis (NASDAQ:OPK) : November 3, 2017 Capital Cube
09:43AM  OPKO Health to Announce 2017 Third Quarter Financial Results on November 8, 2017 GlobeNewswire
Nov-02-17 12:27PM  ETFs with exposure to OPKO Health, Inc. : November 2, 2017 Capital Cube
08:31AM  OPKO Health, Inc. breached its 50 day moving average in a Bearish Manner : OPK-US : November 2, 2017 Capital Cube
08:05AM  Xenetic Biosciences Enters Into Sublicense Agreement Related to its PolyXen Technology with Baxalta Inc., a Wholly-owned Subsidiary of Shire plc Business Wire
Oct-31-17 09:05AM  Xenetic Biosciences Appoints Jeffrey F. Eisenberg as Chief Executive Officer Business Wire
Oct-26-17 10:19AM  OPKO Health Licensee TESARO Announces FDA Approval of VARUBI® IV for Delayed Nausea and Vomiting Associated with Chemotherapy GlobeNewswire
Oct-25-17 08:00AM  Today's Research Reports on Trending Tickers: MannKind and Opko Health ACCESSWIRE
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates Bio-Reference Laboratories, a clinical laboratory that offers laboratory testing services in the detection, diagnosis, evaluation, monitoring, and treatment of diseases. The Bio-Reference Laboratories also provides core genetic testing and leverage products, such as the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. The company's pharmaceutical segment offers Rayaldee, a treatment for secondary hyperparathyroidism in adults with stage 3-4 chronic kidney disease patients with vitamin D deficiency; and VARUBI for chemotherapy-induced nausea and vomiting. This segment is also developing OPK88004, an androgen receptor modulator for benign prostate hypertrophy and other urologic and metabolic conditions; OPK88003, a once or twice weekly oxyntomodulin for type 2 diabetes and obesity; hGH-CTP, a growth hormone injection that is in Phase III clinical trials; and Factor VIIa drug for hemophilia. In addition, it develops and produces specialty active pharmaceutical ingredients; and discovers drugs for the treatment of cancer, heart disease, metabolic disorders, and a range of genetic anomalies. Further, this segment engages in the development, manufacture, marketing, and sale of pharmaceutical, nutraceutical, and veterinary products; and markets and distributes pharmaceutical and natural products. Additionally, OPKO Health, Inc. operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was incorporated in 1991 and is headquartered in Miami, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FROST PHILLIP MD ET ALCEO & ChairmanJul 16Buy5.6815,00085,2494,047,870Jul 17 07:17 AM
Fishel Robert ScottDirectorJul 11Buy6.002,50014,9914,060,728Jul 12 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 03Buy4.7510,00047,5014,032,870Jul 05 07:35 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 29Buy4.717,72036,3354,022,870Jul 02 06:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 28Buy4.6820,00093,6004,015,150Jun 29 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 27Buy4.7510,00047,5003,995,150Jun 28 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 22Buy4.4510,00044,5003,985,150Jun 25 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 21Buy4.5430,000136,2003,975,150Jun 22 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 19Buy4.3220,00086,3003,945,150Jun 20 06:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 18Buy4.3414,29962,0133,925,150Jun 19 06:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 15Buy4.4210,00044,2003,910,851Jun 18 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 11Buy4.2210,00042,2003,900,851Jun 12 06:17 AM
Logal AdamSr. Vice President, CFOJun 08Option Exercise3.4375,000257,250239,858Jun 12 06:05 PM
FROST PHILLIP MD ET ALCEO & ChairmanJun 07Buy4.0410,00040,4003,890,851Jun 08 07:37 AM
FROST PHILLIP MD ET ALCEO & ChairmanJun 06Buy4.0530,000121,5003,880,851Jun 07 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 31Buy3.763,90014,6643,850,851Jun 01 06:49 AM
Fishel Robert ScottDirectorMay 29Buy3.732,5009,3334,058,228May 30 07:29 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 25Buy3.7010,00037,0003,846,951May 29 06:31 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 23Buy3.7340,000149,3003,836,951May 24 06:46 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 22Buy3.7310,00037,3003,796,951May 23 07:15 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 21Buy3.8290,000344,0963,786,951May 22 07:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 18Buy4.04100,000403,7893,696,951May 21 06:24 AM
Fishel Robert ScottDirectorMay 14Buy4.791,8008,6224,055,728May 15 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 04Buy3.1426,00081,5403,596,951May 07 06:58 AM
Fishel Robert ScottDirectorMay 04Buy3.145,00015,7004,053,928May 07 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 03Buy3.0951,800159,9983,570,951May 04 06:57 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 02Buy3.1550,330158,6303,519,151May 03 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanMay 01Buy3.0531,22295,2103,468,821May 02 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 30Buy3.0875,000231,1263,437,599May 01 06:36 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 26Buy3.0331,80096,4493,362,599Apr 27 07:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 25Buy2.9955,372165,3423,330,799Apr 26 06:31 AM
Fishel Robert ScottDirectorApr 25Buy2.9712,50037,1254,048,928Apr 26 06:24 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 24Buy2.9775,000222,6413,275,427Apr 25 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 23Buy3.0475,000227,6553,200,427Apr 24 06:13 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 20Buy3.1260,000187,4903,125,427Apr 23 11:20 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 19Buy3.1710,00031,7003,065,427Apr 20 06:40 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 16Buy3.0250,000150,9503,055,427Apr 17 06:53 AM
Fishel Robert ScottDirectorApr 16Buy3.0115,00045,1004,036,428Apr 17 06:52 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 13Buy2.9930,00089,8003,005,427Apr 16 06:49 AM
Fishel Robert ScottDirectorApr 13Buy3.0210,00030,2004,021,428Apr 16 06:48 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 12Buy3.0465,000197,3002,975,427Apr 13 06:32 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 11Buy3.0643,000131,7272,910,427Apr 12 06:41 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 10Buy3.0636,527111,7062,867,427Apr 11 06:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 09Buy3.0480,000243,0882,830,900Apr 10 08:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 06Buy3.1060,000186,1522,750,900Apr 09 06:04 AM
Fishel Robert ScottDirectorApr 06Buy3.1610,00031,6004,011,428Apr 09 06:07 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 05Buy3.2510,00032,5002,690,900Apr 06 07:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanApr 03Buy3.00153,000458,7902,680,900Apr 04 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 28Buy3.0780,000245,8682,527,900Mar 29 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 27Buy3.2586,100279,6892,447,900Mar 28 06:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 26Buy3.1926,00083,0552,361,800Mar 27 07:14 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 23Buy3.2725,00081,7002,335,800Mar 26 07:11 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 22Buy3.3230,00099,4802,310,800Mar 23 06:45 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 21Buy3.3830,000101,3842,280,800Mar 22 06:47 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 20Buy3.3275,000249,3652,250,800Mar 21 06:34 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 19Buy3.5140,000140,2402,175,800Mar 20 06:21 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 15Buy3.3261,000202,5242,135,800Mar 16 06:54 AM
Logal AdamSr. Vice President, CFOMar 13Buy3.402,0657,011164,858Mar 14 04:07 PM
FROST PHILLIP MD ET ALCEO & ChairmanMar 13Buy3.3667,500227,0072,074,800Mar 14 07:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 12Buy3.4825,00086,9952,007,300Mar 13 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 08Buy3.2832,000104,8351,982,300Mar 09 06:43 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 07Buy3.2975,000246,9461,950,300Mar 08 06:51 AM
Rubin Steven DExecutive VP-AdministrationMar 07Buy3.256,00019,5005,691,915Mar 08 06:49 AM
FROST PHILLIP MD ET ALCEO & ChairmanMar 02Buy2.94364,8001,073,7161,875,300Mar 05 06:29 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 21Buy3.63172,500625,9551,510,500Feb 22 06:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 09Buy3.83185,000708,2911,338,000Feb 12 06:24 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 08Buy4.0420,00080,8321,153,000Feb 09 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 07Buy4.2278,000329,2511,133,000Feb 08 07:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 06Buy4.2260,000252,9411,055,000Feb 07 07:16 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 05Buy4.1450,000206,836995,000Feb 06 06:04 AM
FROST PHILLIP MD ET ALCEO & ChairmanFeb 02Buy4.3055,000236,680945,000Feb 05 07:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 31Buy4.4765,000290,416890,000Feb 01 06:10 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 26Buy4.9055,000269,712825,000Jan 29 06:37 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 25Buy4.9975,000374,204770,000Jan 26 06:55 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 24Buy4.89100,000488,829695,000Jan 25 07:23 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 23Buy4.76100,000476,070595,000Jan 24 07:24 AM
FROST PHILLIP MD ET ALCEO & ChairmanJan 22Buy4.40100,000439,675495,000Jan 23 07:39 AM
Opko Health, Inc.10% OwnerOct 30Buy3.05655,7382,000,0016,678,752Nov 01 04:11 PM
FROST PHILLIP MD ET ALCEO & ChairmanSep 19Buy6.0115,00090,099395,000Sep 20 06:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 18Buy6.0040,000240,000380,000Sep 19 06:26 AM
Logal AdamSr. Vice President, CFOSep 15Buy6.031,5009,045162,793Sep 18 06:09 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 15Buy6.0180,000480,411340,000Sep 18 06:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanSep 14Buy5.98260,0001,555,624260,000Sep 15 08:30 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 25Buy6.1725,000154,236164,234,443Aug 28 06:06 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 24Buy6.2410,00062,353164,209,443Aug 25 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 23Buy6.1312,00073,554164,199,443Aug 24 07:12 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 22Buy6.131,80011,034164,187,443Aug 23 06:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 21Buy6.1025,000152,539164,185,643Aug 22 06:02 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 17Buy5.9650,000298,048164,160,643Aug 18 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 16Buy6.0440,000241,734164,110,643Aug 17 07:19 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 15Buy6.0825,000152,074164,070,643Aug 16 07:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 14Buy6.1510,00061,527164,045,643Aug 15 07:05 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 11Buy6.1910,00061,895164,035,643Aug 14 06:53 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 10Buy6.2339,000242,794164,025,643Aug 11 07:03 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 09Buy6.3518,000114,227163,986,643Aug 10 06:28 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 08Buy6.055,00030,250163,968,643Aug 09 06:54 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 02Buy6.1525,000153,740163,963,643Aug 03 07:25 AM
FROST PHILLIP MD ET ALCEO & ChairmanAug 01Buy6.2546,600291,046163,938,643Aug 02 07:08 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 28Buy6.3035,100221,012163,892,043Jul 31 06:18 AM
FROST PHILLIP MD ET ALCEO & ChairmanJul 27Buy6.3423,600149,687163,856,943Jul 28 06:41 AM